Results 151 to 160 of about 18,601 (174)

Use of anakinra in severe COVID-19: A case report

International Journal of Infectious Diseases, 2020
Alessandra Bandera, Stefano Aliberti, Francesca Minoia   +2 more
exaly  

Current evidence on the use of anakinra in COVID-19

International Immunopharmacology, 2022
Mohammad Solduzian, Elnaz Khani
exaly  

Off-Label studies on anakinra in dermatology: a review

Journal of Dermatological Treatment, 2022
Jeffrey Zhao, Peter A Lio, Giancarlo Atassi   +2 more
exaly  

Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases

Journal of Clinical Medicine, 2022
Yvan Jamilloux, Maximilien Grall, Quitterie Reynaud   +2 more
exaly  

Anakinra

Reactions Weekly, 2015
  +4 more sources

Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis

Cell Host and Microbe, 2020
Quirijn De Mast, Simone Moorlag, Frank Van De Veerdonk   +2 more
exaly  

Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study

European Journal of Preventive Cardiology, 2020
Dimitris Tousoulis, , Giacomo Emmi
exaly  

Effects of anakinra on the small intestine mucositis induced by methotrexate in rats

Experimental Animals, 2020
Murat Cankaya, Emin Murat AkbaŞ, Renad Mammadov   +2 more
exaly  

The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis

Pediatric Blood and Cancer, 2020
Mohamad Badawi, Anshul Vagrecha, Daniel Cannone   +2 more
exaly  

The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases series

Autoimmunity Reviews, 2018
Jethro A Herberg, Isabelle Koné-Paut, Rolando Cimaz   +2 more
exaly